Oxford Biomedica plc (LON:OXB)
643.00
-10.00 (-1.53%)
Oct 10, 2025, 4:35 PM BST
Oxford Biomedica Revenue
Oxford Biomedica had revenue of 73.22M GBP in the half year ending June 30, 2025, with 70.04% growth. This brings the company's revenue in the last twelve months to 151.21M, up 55.44% year-over-year. In the year 2024, Oxford Biomedica had annual revenue of 128.80M with 43.84% growth.
Revenue (ttm)
151.21M
Revenue Growth
+55.44%
P/S Ratio
5.11
Revenue / Employee
168.02K
Employees
850
Market Cap
772.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 128.80M | 39.26M | 43.84% |
Dec 31, 2023 | 89.54M | -50.45M | -36.04% |
Dec 31, 2022 | 139.99M | -2.81M | -1.97% |
Dec 31, 2021 | 142.80M | 55.07M | 62.77% |
Dec 31, 2020 | 87.73M | 23.67M | 36.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Oxford Biomedica News
- 3 days ago - Oxford Biomedica Acquires $4.5 Mln North Carolina Gene Therapy Facility - Nasdaq
- 16 days ago - Oxford BioMedica PLC (OXBDF) (H1 2025) Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 16 days ago - Half Year 2025 Oxford Biomedica PLC Earnings Call Transcript - GuruFocus
- 17 days ago - Oxford Biomedica plc (OXBDF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Oxford Biomedica plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - UK's Oxford Biomedica maintains annual outlook - Reuters
- 3 months ago - OXB completes acquisition of remaining stake in US subsidiary - GlobeNewsWire
- 6 months ago - Oxford Biomedica plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha